MedPath

Effect of ACP on Surgical Repair of Rotator Cuff Tears

Not Applicable
Completed
Conditions
Rotator Cuff Tears
Interventions
Device: Control group
Device: Autologous conditioned plasma
Registration Number
NCT01266226
Lead Sponsor
Schulthess Klinik
Brief Summary

The purpose of this study is to determine if autologous plasma (ACP) is beneficial for better and faster healing following an arthroscopic repair of the rotator cuff.

Detailed Description

The shoulder joint, specially the rotator cuff, is one of the most complicated joints of the human body. If the tendon has to be fixed at the bone during surgery, the weak point in obtaining a successful surgery is the fixation of the tendon at the bone insertion site. Tendon belongs to the bradytrophic tissue conditional on the reduced blood flow, deep mitosis rate and lowered healing potential. We can boost the healing process with a selective use of PRP (platelet rich plasma). In this process, the healing site is delivered with an elevated concentration of thrombocytes and also growth factors which are constituent parts of them.

In this study, we will test the Arthrex® Double Syringe System. With this system it is possible to obtain ACP (Autologous conditioned plasma) in one centrifugation step. The supernatant contains a concentration of thrombocytes which is twice as high as in the native blood. The concentration of the growth factors is 5-25x higher according to this.

We also want to test if one application of ACP is enough to get a short- and long-term benefit in healing following a rotator cuff tear.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
129
Inclusion Criteria
  • Arthroscopic rotator cuff reconstructions of degenerative or traumatic full thickness rotator cuff tears (supraspinatus and/or infraspinatus tendon) performed by Dr. Flury and Dr. Schwyzer
  • Suture bridge technique
  • No pregnancy at the date of the surgery for women of childbearing potential
  • Signed consent form
Exclusion Criteria
  • Partial reconstruction of the rotator cuff (PASTA)
  • Open reconstruction
  • Tendon transfer (latissimus dorsi or pectoralis major)
  • Revision surgery
  • Omarthrosis (Level ≥ 2 Samilson & Prieto)
  • Systemic arthritis
  • Rheumatoid arthritis
  • Diabetes (insulin treated)
  • Requiring surgery in reconstruction of the subscapularis tendon
  • Progressive fat inclusion (fatty infiltration of the rotator cuff musculature Goutallier level IV
  • Acute or chronic infection
  • Pathological bone metabolism
  • Insufficient perfusion in the affected arm
  • Neuromuscular disease in the affected arm
  • Non compliance of the patient
  • Disorders which handicap or inhibit the patient to follow the orders of the clinical testers

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Control groupControl groupThe patients are going to get an injection of 4mL saline solution under the footprint following an arthroscopic repair of the rotator cuff.
ACP treatedAutologous conditioned plasmaThe patients are going to get an injection of 4mL autologous conditioned plasma under the footprint following an arthroscopic repair of the rotator cuff.
Primary Outcome Measures
NameTimeMethod
Oxford Shoulder Score3mo (6mo/24mo)

The Oxford Shoulder Score used after 3 months is the primary parameter. The Score tests the ability to participate in the patients' normal life before they got injured.

Secondary Outcome Measures
NameTimeMethod
EQ-5D3/6/24 mo
VAS Pain10d po
MRI/X-Ray/Ultrasonic Diagnostics6/24 mo
ASES Score3/6/24mo
Constant Murley Score3/6/24 mo
Measurement of the external rotation strenght3/6/24 mo
QuickDASH3/6/24mo
ROM3/6/24mo
Measurement of the abduction strength3/6/24 mo

Trial Locations

Locations (1)

Schulthess Klinik

🇨🇭

Zürich, Canton Zürich, Switzerland

© Copyright 2025. All Rights Reserved by MedPath